跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
EBGLYSS 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
EBGLYSS 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Almirall S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 21, 2023
Approval ID
3f24d90927291056
Company
Almirall S.A.
Type
Standard
Approval Details
Approval Id
3f24d90927291056
Drug Cima Aemps Name
EBGLYSS 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number
1231765001
Holder Company Name
Almirall S.A.
Marketing Company Name
Almirall S.A.
Holder Company Detail Path
/organization/almirall-sa
Marketing Company Detail Path
/organization/almirall-sa
Authorization Date
2023-12-21
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
250 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Almirall S.A.
Company Detail Path
/organization/almirall-sa
Company Information
Pharmaceutical Company Name
ALMIRALL SA
Country Name
Spain
City Name
barcelona,barcelona,country_es
Address
RONDA GENERAL MITRE, 151 - 6
Website
http://www.almirall.com
Active Ingredients
LEBRIKIZUMAB
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 21, 2023
Approval ID
3f24d90927291056
Type
Standard
Back to CIMA-AEMPS Approvals